Results 291 to 300 of about 314,387 (344)

Exploring the impact of Cabotegravir‐Rilpivirine long‐acting on weight gain, body composition and quality of life in adults living with HIV

HIV Medicine, EarlyView.
Abstract Introduction Long‐acting injectable antiretroviral therapy (ART) with Cabotegravir (CAB) and Rilpivirine (RPV) offers an alternative to daily oral regimens, improving adherence and patient satisfaction. However, its impact on body composition and metabolism remains underexplored.
Andrea De Vito, Andrea Marongiu, Antonella Cano, Mariangela Puci, Agnese Colpani, Susanna Maria Nuvoli, Maria Grazia Catte, Giulia Moi, Maria Antonietta Deledda, Sergio Uzzau, Giovanni Sotgiu, Franca Deriu, Angela Spanu, Giordano Madeddu   +13 more
wiley   +1 more source

Optimising HIV drug resistance testing laboratory networks in Kenya: insights from systems engineering modelling. [PDF]

BMJ Open
Wang Y, Kingwara L, Wagner AD, Yongo N, Hassan SA, Liu S, Oyaro P, Patel RC.   +7 more
europepmc   +1 more source

Low HIV drug resistance prevalence among recently diagnosed HIV-positive men who have sex with men in a setting of high PrEP use. [PDF]

J Int AIDS Soc
King JM, Giallonardo FD, Shaik A, McGregor S, Yeung JYK, Sivaruban T, Lee FJ, Cunningham P, Dwyer DE, Nigro SJ, Grulich AE, Kelleher AD.   +11 more
europepmc   +1 more source

Prevalence of HIV Drug Resistance Mutations among Treatment-Naive People Living with HIV in a Tertiary Care Center in India. [PDF]

Am J Trop Med Hyg
Srivastva S, Chakravarty J, Kushwaha AK.
europepmc   +1 more source

Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy. [PDF]

J Acquir Immune Defic Syndr
Dorward J, Sookrajh Y, Lessells R, Bulo E, Bodley N, Singh L, Moodley P, Samsunder N, Drain PK, Hayward G, Butler CC, Garrett N.   +11 more
europepmc   +1 more source

Virologic Nonsuppression and HIV Drug Resistance Among People Who Inject Drugs and Their Sexual and Injecting Partners in Kenya. [PDF]

AIDS Res Hum Retroviruses
Chohan BH, Kingston H, Tseng AS, Sambai B, Guthrie BL, Wilkinson E, Giandhari J, Mbogo LW, Monroe-Wise A, Masyuko S, Bosire R, Ludwig-Barron NT, Sinkele W, Bukusi D, de Oliveria T, Farquhar C, Herbeck JT.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HIV Drug Resistance

2023
Abstract According to the Centers for Disease Control and Prevention (2022), approximately 35% of persons with diagnosed HIV infection in the United States do not have a suppressed viral load, underscoring ongoing gaps in HIV care—many of which were exacerbated with the COVID-19 pandemic.
Carolyn Chu, Avani Dalal, Robert W. Shafer   +2 more
openaire   +1 more source

HIV Drug Resistance

Annual Review of Pharmacology and Toxicology, 1992
Infection with human immunodeficiency virus (HIV) is a chronic process with persistent, high rates of replication. The virus exhibits high rates of mutation over time within the same individual. It is thus not surprising that drug-resis­ tant mutants of HIV emerge under the selective pressure of prolonged chemotherapy, especially with the knowledge of ...
openaire   +3 more sources

Selection of drug-resistant HIV

Trends in Microbiology, 1999
Resistance to antiretroviral drugs by HIV develops from competition among several different virus variants within an individual. Recent studies have measured the changing proportions of HIV populations, which differ by single nucleic acids, under the selective pressures exerted by the addition or removal of antiretroviral drugs.
P R, Harrigan, C S, Alexander
openaire   +2 more sources